Tero Aittokallio profile picture
Tero
Aittokallio
InFLAMES Flagship
Docent, Faculty of Science
PhD

Contact

Tykistökatu 6 A
20520
Turku

Biography

Tero Aittokallio received his PhD in Applied Mathematics from the University of Turku in 2001, under the supervision of Prof. Mats Gyllenberg. He then did his post-doctoral training in the Systems Biology Lab at the Institut Pasteur (2006-2007), with Dr. Benno Schwikowski, where he focused on network biology applications using high-throughput experimental assays and network analysis tools such as Cytoscape. In 2007, Dr. Aittokallio launched his independent career as a principal investigator in the Turku Biomathematics Research Group, where he received a five-year appointment as an Academy of Finland Research Fellow (2007-2012). Tero Aittokallio joined Institute for Molecular Medicine Finland (FIMM) as EMBL Group Leader in the fall of 2011, and was selected as Professor of Statistics and Applied Mathematics at University of Turku in 2015.

Teaching

Computational statistics.

Scientific computing.

Research

Aittokallio's research group focuses on developing and applying integrated computational-experimental approaches to tackle biomedical questions, such as how genes function as interaction networks to carry out and regulate cellular processes, how alterations in these networks contribute to complex traits, such as human diseases, and where and how in the disease network one should target to optimally inhibit the disease phenotypes, such as tumor growth.

Publications

Sort by:

Development of a cancer pharmacopeia-wide ex-vivo drug sensitivity and resistance testing (DSRT) platform for AML: Towards individually optimized therapy and improved understanding of drug resistance patterns (2012)

Cancer Research
Malani D, Pemovska T, Kontro M, Murumagi A, Kulesskiy E, Yadav B, Bespalov M, Eldfors S, Elonen E, Karjalainen R, Knowles JKC, Majumder MM, Mpindi JP, Edgren H, Szwajda A, Venkata NPK, Turunen L, Mustjoki S, Wolf M, Aittokallio T, Heckman CA, Porkka K, Wennerberg K, Kallioniemi O
(Muu (O2))

High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgroups of Relapsed Chemorefractory AML (2012)

Blood
Heckman CA, Kontro M, Pemovska T, Eldfors S, Edgren H, Kulesskiy E, Majumder MM, Karjalainen R, Yadav B, Szwajda A, Venkata NPK, Murumagi A, Malani D, Parsons A, Hintsanen P, Almusa H, Marti JML, Ellonen P, Mattila P, Lepisto M, Lagstrom S, Suvela M, Mustjoki S, Saarela J, Aittokallio T, Kallioniemi O, Wennerberg K, Porkka K
(Muu (O2))